ERBB2 and neoplasm: Smoldering inflammation in the tumor microenvironment enhances pro-oncogenes (such as RAS, MYC and HER2) while potentially inhibiting tumor suppressor genes (such as p53, BRCA1 and PTEN), resulting in genomic instability and tumorigenesis [12,13].